We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$415M
AUM Growth
+$44.4M
Cap. Flow
+$47.9M
Cap. Flow %
11.55%
Top 10 Hldgs %
45.62%
Holding
96
New
27
Increased
21
Reduced
16
Closed
26

Top Buys

Rank Stock Value
1
WCG
Wellcare Health Plans, Inc.
WCG
+$11.3M
2
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$10.7M
3
LJPC
La Jolla Pharmaceutical Company
LJPC
+$9.88M
4
BEAT
BioTelemetry, Inc.
BEAT
+$8.09M
5
ELV icon
Elevance Health
ELV
+$8.01M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$18.6M
2
GILD icon
Gilead Sciences
GILD
+$16M
3
CVS icon
CVS Health
CVS
+$13.6M
4
ASND icon
Ascendis Pharma A/S
ASND
+$10.6M
5
NVO
Novo Nordisk
NVO
+$8.47M

Sector Composition

Rank Sector Weight
1 Healthcare 69.13%
2 Technology 1.01%
3 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISRG icon
76
PUT
Intuitive Surgical
ISRG
$127B
– –
-29,700
Closed -$5.65M
LXRX icon
77
PUT
Lexicon Pharmaceuticals
LXRX
$1.03B
– –
-21,600
Closed -$120K
MASI
78
PUT
DELISTED
Masimo
MASI
– –
-3,300
Closed -$456K
MCK icon
79
McKesson
MCK
$104B
– –
-51,300
Closed -$6M
NVO
80
Novo Nordisk
NVO
$228B
– –
-324,000
Closed -$8.47M
PEN icon
81
PUT
Penumbra
PEN
$12.6B
– –
-24,000
Closed -$3.53M
PETS icon
82
PetMed Express
PETS
$42.3M
– –
-178,151
Closed -$4.06M
RIGL icon
83
Rigel Pharmaceuticals
RIGL
$723M
– –
-160,927
Closed -$4.14M
SNY icon
84
Sanofi
SNY
$107B
– –
-156,854
Closed -$6.95M
SYK icon
85
PUT
Stryker
SYK
$135B
– –
-19,200
Closed -$3.79M
VTAK icon
86
Catheter Precision
VTAK
$1.02M
– –
-1
Closed -$590K
WBA
87
PUT
DELISTED
Walgreens Boots Alliance
WBA
– –
-165,500
Closed -$10.5M
SRCL
88
DELISTED
Stericycle Inc
SRCL
– –
-75,000
Closed -$4.08M
EGRX
89
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
– –
-84,695
Closed -$4.28M
CBAY
90
DELISTED
Cymabay Therapeutics
CBAY
– –
-239,827
Closed -$3.19M
ICPT
91
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-21,800
Closed -$2.44M
RVLP
92
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
– –
-346,410
Closed -$1.25M
CCXI
93
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-530,175
Closed -$6.14M
GWPH
94
PUT
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-50,800
Closed -$8.56M
VAR
95
PUT
DELISTED
Varian Medical Systems, Inc.
VAR
– –
-27,600
Closed -$3.91M
IDXG
96
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
– –
-165,310
Closed -$1.32M
1 2 3
4

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $698M AUM 17.36% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
TCM
Tensile Capital Management Larkspur, California $698M AUM 2.4% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
SAM
Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return

Sio Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Sio Capital Management held 96 positions worth $415M, up 12% from $370M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Sio Capital Management deployed $47.9M of net new capital in Q2 2019, opening 27 new positions and adding to 21 existing holdings. Its largest new stake was La Jolla Pharmaceutical Company: 1,310,367 shares worth $12.1M.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, down from 81% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was CVS Health, an estimated $13.6M trimmed.

  • Sio Capital Management's largest Q2 2019 buy was La Jolla Pharmaceutical Company: 1,310,367 shares worth $12.1M.
  • Sio Capital Management added most to Wellcare Health Plans, Inc. in Q2 2019, an estimated $11.3M increase.
  • Sio Capital Management's biggest Q2 2019 reduction was CVS Health, cutting an estimated $13.6M.
  • Sio Capital Management fully exited Biogen in Q2 2019, selling an estimated $18.6M.
  • Sio Capital Management's ten largest holdings make up 46% of its $415M portfolio in Q2 2019.
  • Sio Capital Management opened 27 new positions and closed 26 in Q2 2019.
  • Sio Capital Management's portfolio value rose 12% quarter-over-quarter to $415M.

Based on Sio Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.